Clinical Advances in Hematology and Oncology : Impact Factor & More
eISSN: 1543-0790pISSN: 1543-0790
Share this on:
Key Metrics
CiteScore 
1.2
SJR
Q4Oncology
SNIP
0.67
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Clinical Advances in Hematology and Oncology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | MILLENNIUM MEDICAL PUBLISHING, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in Clinical Advances in Hematology and Oncology
The evolution of treatment for uveal melanoma.
- 1 Feb 2026
- Clinical advances in hematology & oncology : H&O
Optimal treatment for metastatic HER2+ breast cancer.
- 1 Feb 2026
- Clinical advances in hematology & oncology : H&O
Highlights in multiple myeloma from the 2025 American Society of Hematology Annual Meeting.
- 1 Feb 2026
- Clinical advances in hematology & oncology : H&O
The clinical applications of next-generation sequencing and ctDNA/cfDNA in lymphoma.
- 1 Feb 2026
- Clinical advances in hematology & oncology : H&O
When will circulating tumor DNA be ready for prime time in lymphoma?
- 1 Feb 2026
- Clinical advances in hematology & oncology : H&O
Highlights in chronic lymphocytic leukemia from the 67th ASH Annual Meeting and Exposition.
- 1 Feb 2026
- Clinical advances in hematology & oncology : H&O
The evolution of treatment for uveal melanoma.
- 1 Feb 2026
- Clinical advances in hematology & oncology : H&O
Optimal treatment for metastatic HER2+ breast cancer.
- 1 Feb 2026
- Clinical advances in hematology & oncology : H&O
Highlights in multiple myeloma from the 2025 American Society of Hematology Annual Meeting.
- 1 Feb 2026
- Clinical advances in hematology & oncology : H&O
The clinical applications of next-generation sequencing and ctDNA/cfDNA in lymphoma.
- 1 Feb 2026
- Clinical advances in hematology & oncology : H&O
When will circulating tumor DNA be ready for prime time in lymphoma?
- 1 Feb 2026
- Clinical advances in hematology & oncology : H&O
Highlights in chronic lymphocytic leukemia from the 67th ASH Annual Meeting and Exposition.
- 1 Feb 2026
- Clinical advances in hematology & oncology : H&O
FAQs on Clinical Advances in Hematology and Oncology
How long has Clinical Advances in Hematology and Oncology been actively publishing? 
What is the publishing frequency of Clinical Advances in Hematology and Oncology?
How many articles did Clinical Advances in Hematology and Oncology publish last year?
What is the eISSN & pISSN for Clinical Advances in Hematology and Oncology?
What is Citescore for Clinical Advances in Hematology and Oncology?
What is SNIP score for Clinical Advances in Hematology and Oncology?
What is the SJR for Clinical Advances in Hematology and Oncology?
Who is the publisher of Clinical Advances in Hematology and Oncology?
